554
F. Tourniaire et al.
Karkeni, E., Astier, J., Tourniaire, F., El Abed, M., Romier, B., Gouranton, E., et al. (2016). Obesityassociated Inflammation Induces microRNA-155 Expression in Adipocytes and Adipose Tissue:
Outcome on Adipocyte Function. Journal of Clinical Endocrinology and Metabolism, 101(4),
1615–1626.
Karkeni, E., Bonnet, L., Marcotorchino, J., Tourniaire, F., Astier, J., Ye, J., et al. (2017). Vitamin
D limits inflammation-linked microRNA expression in adipocytes in vitro and in vivo: a new
mechanism for the regulation of inflammation by vitamin D. Epigenetics.
Karkeni, E., Bonnet, L., Astier, J., Couturier, C., Dalifard, J., Tourniaire, F., et al. (2017b). Alltrans-retinoic acid represses chemokine expression in adipocytes and adipose tissue by inhibiting
NF-κB signaling. Journal of Nutritional Biochemistry, 42, 101–107.
Kawada, T., Kamei, Y., Fujita, A., Hida, Y., Takahashi, N., Sugimoto, E., et al. (2000). Carotenoids
and retinoids as suppressors on adipocyte differentiation via nuclear receptors. BioFactors, 13(1–
4), 103–109.
Kim, B., Farruggia, C., Ku, C. S., Pham, T. X., Yang, Y., Bae, M., et al. (2017). Astaxanthin inhibits
inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity
and nonalcoholic steatohepatitis. Journal of Nutritional Biochemistry, 43, 27–35.
Kimmons, J. E., Blanck, H. M., Tohill, B. C., Zhang, J., & Khan, L. K. (2006). Associations between
body mass index and the prevalence of low micronutrient levels among US adults. Medscape
General Medicine, 8(4), 59.
Kirby, M. L., Beatty, S., Stack, J., Harrison, M., Greene, I., & McBrinn, S., et al. (2011). Changes in
macular pigment optical density and serum concentrations of lutein and zeaxanthin in response
to weight loss. British Journal of Nutrition, 1–11.
Kuhad, A., Sethi, R., Chopra, K. (2008). Lycopene attenuates diabetes-associated cognitive decline
in rats. Life Science, 83(3–4), 128–134.
Landrier, J. F. (2012). Les phytomicronutriments. In A. Lavoisier (Ed.), Paris: Tec & doc.
Landrier, J. F., Marcotorchino, J., & Tourniaire, F. (2012). Lipophilic micronutrients and adipose
tissue biology. Nutrients, 4(11), 1622–1649.
Landrier, J. F., Kasiri, E., Karkeni, E., Mihaly, J., Beke, G., Weiss, K., et al. (2017). Reduced
adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1
and further retinoic acid receptor signaling in adipose tissue. FASEB Journal, 31(1), 203–211.
Li, C. C., Liu, C., Fu, M., Hu, K. Q., Aizawa, K., Takahashi, S., et al. (2018). Tomato powder inhibits
hepatic steatosis and inflammation potentially through restoring SIRT1 activity and Adiponectin
function independent of carotenoid cleavage enzymes in mice. Molecular Nutrition & Food
Research, 62(8), e1700738.
Liu, M., Liu, H., Xie, J., Xu, Q., Pan, C., Wang, J., et al. (2017). Anti-obesity effects of zeaxanthin
on 3T3-L1 preadipocyte and high fat induced obese mice. Food & Function, 8(9), 3327–3338.
Liu, M., Zheng, M., Cai, D., Xie, J., Jin, Z., Liu, H., et al. (2019). Zeaxanthin promotes mitochondrial
biogenesis and adipocyte browning via AMPKalpha1 activation. Food & Function, 10(4), 2221–
2233.
Lobo, G. P., Amengual, J., Li, H. N., Golczak, M., Bonet, M. L., Palczewski, K., et al. (2010).
Beta, beta-carotene decreases peroxisome proliferator receptor gamma activity and reduces lipid
storage capacity of adipocytes in a beta, beta-carotene oxygenase 1-dependent manner. Journal
of Biological Chemistry, 285(36), 27891–27899.
Maeda, H. (2015). Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review.
Journal of Oleo Science, 64(2), 125–132.
Maeda, H., Hosokawa, M., Sashima, T., Takahashi, N., Kawada, T., & Miyashita, K. (2006). Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
International Journal of Molecular Medicine, 18(1), 147–152.
Maeda, H., Kanno, S., Kodate, M., Hosokawa, M., & Miyashita, K. (2015). Fucoxanthinol, metabolite of fucoxanthin, improves obesity-induced inflammation in adipocyte cells. Marine Drugs,
13(8), 4799–4813.
F. Tourniaire et al.
Karkeni, E., Astier, J., Tourniaire, F., El Abed, M., Romier, B., Gouranton, E., et al. (2016). Obesityassociated Inflammation Induces microRNA-155 Expression in Adipocytes and Adipose Tissue:
Outcome on Adipocyte Function. Journal of Clinical Endocrinology and Metabolism, 101(4),
1615–1626.
Karkeni, E., Bonnet, L., Marcotorchino, J., Tourniaire, F., Astier, J., Ye, J., et al. (2017). Vitamin
D limits inflammation-linked microRNA expression in adipocytes in vitro and in vivo: a new
mechanism for the regulation of inflammation by vitamin D. Epigenetics.
Karkeni, E., Bonnet, L., Astier, J., Couturier, C., Dalifard, J., Tourniaire, F., et al. (2017b). Alltrans-retinoic acid represses chemokine expression in adipocytes and adipose tissue by inhibiting
NF-κB signaling. Journal of Nutritional Biochemistry, 42, 101–107.
Kawada, T., Kamei, Y., Fujita, A., Hida, Y., Takahashi, N., Sugimoto, E., et al. (2000). Carotenoids
and retinoids as suppressors on adipocyte differentiation via nuclear receptors. BioFactors, 13(1–
4), 103–109.
Kim, B., Farruggia, C., Ku, C. S., Pham, T. X., Yang, Y., Bae, M., et al. (2017). Astaxanthin inhibits
inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity
and nonalcoholic steatohepatitis. Journal of Nutritional Biochemistry, 43, 27–35.
Kimmons, J. E., Blanck, H. M., Tohill, B. C., Zhang, J., & Khan, L. K. (2006). Associations between
body mass index and the prevalence of low micronutrient levels among US adults. Medscape
General Medicine, 8(4), 59.
Kirby, M. L., Beatty, S., Stack, J., Harrison, M., Greene, I., & McBrinn, S., et al. (2011). Changes in
macular pigment optical density and serum concentrations of lutein and zeaxanthin in response
to weight loss. British Journal of Nutrition, 1–11.
Kuhad, A., Sethi, R., Chopra, K. (2008). Lycopene attenuates diabetes-associated cognitive decline
in rats. Life Science, 83(3–4), 128–134.
Landrier, J. F. (2012). Les phytomicronutriments. In A. Lavoisier (Ed.), Paris: Tec & doc.
Landrier, J. F., Marcotorchino, J., & Tourniaire, F. (2012). Lipophilic micronutrients and adipose
tissue biology. Nutrients, 4(11), 1622–1649.
Landrier, J. F., Kasiri, E., Karkeni, E., Mihaly, J., Beke, G., Weiss, K., et al. (2017). Reduced
adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1
and further retinoic acid receptor signaling in adipose tissue. FASEB Journal, 31(1), 203–211.
Li, C. C., Liu, C., Fu, M., Hu, K. Q., Aizawa, K., Takahashi, S., et al. (2018). Tomato powder inhibits
hepatic steatosis and inflammation potentially through restoring SIRT1 activity and Adiponectin
function independent of carotenoid cleavage enzymes in mice. Molecular Nutrition & Food
Research, 62(8), e1700738.
Liu, M., Liu, H., Xie, J., Xu, Q., Pan, C., Wang, J., et al. (2017). Anti-obesity effects of zeaxanthin
on 3T3-L1 preadipocyte and high fat induced obese mice. Food & Function, 8(9), 3327–3338.
Liu, M., Zheng, M., Cai, D., Xie, J., Jin, Z., Liu, H., et al. (2019). Zeaxanthin promotes mitochondrial
biogenesis and adipocyte browning via AMPKalpha1 activation. Food & Function, 10(4), 2221–
2233.
Lobo, G. P., Amengual, J., Li, H. N., Golczak, M., Bonet, M. L., Palczewski, K., et al. (2010).
Beta, beta-carotene decreases peroxisome proliferator receptor gamma activity and reduces lipid
storage capacity of adipocytes in a beta, beta-carotene oxygenase 1-dependent manner. Journal
of Biological Chemistry, 285(36), 27891–27899.
Maeda, H. (2015). Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review.
Journal of Oleo Science, 64(2), 125–132.
Maeda, H., Hosokawa, M., Sashima, T., Takahashi, N., Kawada, T., & Miyashita, K. (2006). Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
International Journal of Molecular Medicine, 18(1), 147–152.
Maeda, H., Kanno, S., Kodate, M., Hosokawa, M., & Miyashita, K. (2015). Fucoxanthinol, metabolite of fucoxanthin, improves obesity-induced inflammation in adipocyte cells. Marine Drugs,
13(8), 4799–4813.